<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Michael J. Evans:  Law + Technology + Marketing &#187; thromboembolism</title>
	<atom:link href="http://www.mjevans.com/tag/thromboembolism/feed" rel="self" type="application/rss+xml" />
	<link>http://www.mjevans.com</link>
	<description>How lawyers can use the Internet, social media, online video, and technology to attract clients, be more effective, make more money, and have more fun.</description>
	<lastBuildDate>Tue, 07 Feb 2012 04:54:16 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Yaz, Yasmin ads must be updated to add risks of thromboembolism</title>
		<link>http://www.mjevans.com/dangerous-products/yaz-yasmin-ads-must-be-updated-to-add-risks-of-thromboembolism</link>
		<comments>http://www.mjevans.com/dangerous-products/yaz-yasmin-ads-must-be-updated-to-add-risks-of-thromboembolism#comments</comments>
		<pubDate>Mon, 19 Apr 2010 16:49:47 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[thromboembolism]]></category>
		<category><![CDATA[Yasmin]]></category>
		<category><![CDATA[Yaz]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=785</guid>
		<description><![CDATA[The Food and Drug Administration is requiring Bayer, the maker of Yaz/Yasmin birth control pills, to change its ads and promotional materials to add information about the risk of thromboembolism.  Bayer recently changed the drugs&#8217;s warning labels to include information about the risk of thromboembolism in women using Yasmin compared to contraceptives using other progestins. [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/dangerous-products/yaz-yasmin-ads-must-be-updated-to-add-risks-of-thromboembolism/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

